| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.02 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.069 | 0.02 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |